Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.

PubWeight™: 2.35‹?› | Rank: Top 2%

🔗 View Article (PMID 22344404)

Published in Radiology on February 17, 2012

Authors

Kewalee Sasiwimonphan1, Naoki Takahashi, Bradley C Leibovich, Rickey E Carter, Thomas D Atwell, Akira Kawashima

Author Affiliations

1: Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.

Articles citing this

Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging (2014) 1.25

Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours. Eur Radiol (2014) 0.90

Imaging findings of common benign renal tumors in the era of small renal masses: differential diagnosis from small renal cell carcinoma: current status and future perspectives. Korean J Radiol (2015) 0.89

Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol (2016) 0.89

MRI phenotype in renal cancer: is it clinically relevant? Top Magn Reson Imaging (2014) 0.86

Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. Clin Genitourin Cancer (2013) 0.85

Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. Clin Genitourin Cancer (2015) 0.84

Study of 320-slice dynamic volume CT perfusion in different pathologic types of kidney tumor: preliminary results. PLoS One (2014) 0.84

Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. PLoS One (2014) 0.82

Fat-poor angiomyolipoma and renal cell carcinoma: differentiation with MR imaging and accuracy of histopathologic evaluation. Radiology (2012) 0.80

Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma. Eur Radiol (2014) 0.78

Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction. Quant Imaging Med Surg (2017) 0.78

Qualitative and quantitative analysis with contrast-enhanced ultrasonography: diagnosis value in hypoechoic renal angiomyolipoma. Korean J Radiol (2015) 0.78

Intracellular lipid in papillary renal cell carcinoma (pRCC): T2 weighted (T2W) MRI and pathologic correlation. Eur Radiol (2015) 0.78

Imaging of Solid Renal Masses. Radiol Clin North Am (2016) 0.77

Angiomyolipoma (AML) without visible fat: Ultrasound, CT and MR imaging features with pathological correlation. Eur Radiol (2015) 0.77

Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions. Radiol Med (2015) 0.75

Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours. Eur J Cancer (2016) 0.75

Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management. Semin Ultrasound CT MR (2016) 0.75

Xp11.2 translocation renal cell carcinoma with egg-shell calcification mimicking a benign renal tumour: A case report. Oncol Lett (2015) 0.75

Enhancement pattern of angiomyolipoma without visible fat versus that of renal cell carcinoma. Radiology (2012) 0.75

Imaging and Management of Incidental Renal Lesions. Biomed Res Int (2017) 0.75

MRI evaluation of small (<4cm) solid renal masses: multivariate modeling improves diagnostic accuracy for angiomyolipoma without visible fat compared to univariate analysis. Eur Radiol (2015) 0.75

Articles by these authors

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res (2006) 8.21

Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol (2008) 5.30

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A (2004) 5.13

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00

Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70

Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33

Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol (2010) 3.71

Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology (2014) 3.54

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis (2012) 3.47

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res (2003) 3.25

Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24

PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res (2007) 3.23

Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer (2006) 3.08

Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol (2012) 2.73

Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69

Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol (2004) 2.61

EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc (2007) 2.61

Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61

Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol (2012) 2.52

Retracted Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. J Clin Oncol (2010) 2.49

Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology (2014) 2.45

Treatment of patients with small renal masses: a survey of the American Urological Association. J Urol (2010) 2.45

The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur Urol (2008) 2.40

Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol (2010) 2.38

The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol (2007) 2.36

Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31

Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut (2010) 2.29

Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int (2012) 2.28

Prediction of pancreatic anastomotic failure after pancreatoduodenectomy: the use of preoperative, quantitative computed tomography to measure remnant pancreatic volume and body composition. Ann Surg (2013) 2.26

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum (2012) 2.25

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A (2006) 2.24

The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis. Eur Urol (2013) 2.19

The noninferiority of the nonparticulate steroid dexamethasone vs the particulate steroids betamethasone and triamcinolone in lumbar transforaminal epidural steroid injections. Pain Med (2013) 2.17

Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol (2007) 2.15

Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol (2005) 2.10

A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol (2009) 2.06

Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol (2009) 2.05

Extravascular lung water and pulmonary vascular permeability index as markers predictive of postoperative acute respiratory distress syndrome: a prospective cohort investigation. Crit Care Med (2015) 2.05

Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients. Crit Care Med (2011) 2.03

Radiation exposure and pregnancy: when should we be concerned? Radiographics (2007) 2.03

Effects of experimental sleep restriction on caloric intake and activity energy expenditure. Chest (2013) 2.02

Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol (2005) 2.01

Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma. Cancer (2009) 2.00

The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int (2004) 2.00

Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res (2008) 1.97

A prospective study of health and risk of mortality after spinal cord injury. Arch Phys Med Rehabil (2008) 1.93

Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol (2010) 1.93

Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient. Urology (2009) 1.92

Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol (2011) 1.92

Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology (2013) 1.91

Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int (2012) 1.87

Prediction of human observer performance in a 2-alternative forced choice low-contrast detection task using channelized Hotelling observer: impact of radiation dose and reconstruction algorithms. Med Phys (2013) 1.86

Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol (2007) 1.83

Size-specific dose estimates for adult patients at CT of the torso. Radiology (2012) 1.83

Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol (2008) 1.83

Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer (2011) 1.80

Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol (2009) 1.80

Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol (2010) 1.76

Peroral endoscopic drainage/debridement of walled-off pancreatic necrosis. Ann Surg (2007) 1.76

Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. Eur Urol (2011) 1.74

Outcomes following partial nephrectomy by tumor size. J Urol (2008) 1.72

Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol (2004) 1.71

Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma. Cancer (2005) 1.71

MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol (2008) 1.69

Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut (2012) 1.67

Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci (2011) 1.67

Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery (2012) 1.64

Risk of mortality after spinal cord injury: an 8-year prospective study. Arch Phys Med Rehabil (2009) 1.63

Histologic and imaging features of mural nodules in mucinous pancreatic cysts. Clin Gastroenterol Hepatol (2011) 1.61

Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol (2008) 1.60

Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res (2007) 1.59

Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up. BJU Int (2013) 1.59

Classification and expression analysis of Arabidopsis F-box-containing protein genes. Plant Cell Physiol (2002) 1.59

T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Clin Cancer Res (2008) 1.58

Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort. J Urol (2011) 1.57

Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology (2007) 1.56

Multicenter evaluation of an investigational prostate cancer methylation assay. J Urol (2009) 1.56

Percutaneous renal cryoablation: local control at mean 26 months of followup. J Urol (2010) 1.55

Behavioral risk factors of mortality after spinal cord injury. Arch Phys Med Rehabil (2009) 1.55

Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol (2009) 1.55

Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol (2005) 1.55

Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations. J Vasc Interv Radiol (2012) 1.54

Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients. BJU Int (2014) 1.54

Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. J Urol (2007) 1.53

Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology (2012) 1.52

Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes (2013) 1.51

Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology (2011) 1.49

Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology (2009) 1.48

A comparison of direct endoscopic necrosectomy with transmural endoscopic drainage for the treatment of walled-off pancreatic necrosis. Gastrointest Endosc (2009) 1.47

Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis. Radiology (2006) 1.46

ydk1-D, an auxin-responsive GH3 mutant that is involved in hypocotyl and root elongation. Plant J (2004) 1.46

Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes (2012) 1.46

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer (2008) 1.45

Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol (2010) 1.45

Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease. Mayo Clin Proc (2005) 1.44

Percutaneous cryoablation of solitary sporadic renal cell carcinomas. BJU Int (2012) 1.44

Effect of whole-body vibration exercise and muscle strengthening, balance, and walking exercises on walking ability in the elderly. Keio J Med (2007) 1.43